HODGKIN LYMPHOMA DRUG PIPELINE ANALYSIS: MARKET GROWTH AND FUTURE TREND (2034)

Hodgkin lymphoma (HL) is a rare but serious cancer that originates in the lymphatic system, a vital component of the immune system. Characterized by the abnormal growth of lymphocytes, it compromises immune function and can spread to other parts of the body. While representing only about 0.4% of newly reported cancer cases globally and contributing